Camber Capital Management LP Gilead Sciences, Inc. Transaction History

Camber Capital Management LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $144 Million - $163 Million	-2,500,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $14.5 Million - $18.1 Million	250,000 Added 11.11%	2,500,000 $149 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $74.6 Million - $84.7 Million	1,150,000 Added 104.55%	2,250,000 $163 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $20.3 Million - $21.9 Million	-300,000 Reduced 21.43%	1,100,000 $76.8 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $25.4 Million - $27.7 Million	400,000 Added 40.0%	1,400,000 $96.4 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $60 Million - $68.5 Million	1,000,000 New	1,000,000 $64.6 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $93.9 Million - $120 Million	-1,500,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $92.4 Million - $102 Million	1,500,000 New	1,500,000 $97.5 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $62.5 Million - $69 Million	-1,000,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $61.9 Million - $69.4 Million	1,000,000 New	1,000,000 $67.6 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $35.6 Million - $41.8 Million	-500,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $36.1 Million - $42.7 Million	500,000	500,000 $40.5 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.